个人简介
刘宝瑞，主任医师、教授、博士生导师、美国MD Anderson Cancer Center 博士后；南京鼓楼医院副院长、肿瘤中心主任。中国医师奖获得者、全国医药卫生系统先进个人、江苏省有突出贡献专家、江苏省优秀医学人才，享受国务院特殊津贴。
研究领域
靶向与个体化治疗、个体化肿瘤疫苗、现代化抗肿瘤中药研究
近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1.Bilateral breast metastasis from small cell carcinoma of the ovary. J Clin Oncol. 2008; 26(31):5129-5130
2.mRNA Expression of BRCA1, PIAS1, and PIAS4 and Survival After Second-line Docetaxel in Advanced Gastric Cancer. Journal of the National Cancer Institute. 2011;103(20):1152-1156
3.Targeted de livery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases- stimuli nanoparticles，Biomaterials，2013;34(29):7191-203
4.Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy. Journal of Controlled Release. 2015 Feb; 200:188–200
5.Tumor delivery efficiency and apoptosis enhancement by EVO nanoparticles on murie hepatic carcinoma cell line H22. J Biomed Nanotechnol. 2013;9(8):1354-61
京公网安备 11010802027423号